Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Public Health

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

Value in Health

English

Subjective Financial Burden Among German Cancer Patients - Relationship of the Patients’ Economic Situation and Subjective Distress

English

Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward

English

HT3 Understanding the Complexity of HTA Networks

English

Pmu72 - Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the Fda, 2015-2016

English

Pnd79 - Reduced Healthcare Resource Utilisation for Patients Treated With Delayed Release Dimethyl Fumarate vs Injectable Therapies: Findings From a Real-World Cross-Sectional Study of Ms Patients

English

Pnd96 - Four-Year Resource Use and Costs Associated With Administration and Monitoring of Disease Modifying Drugs in Patients With Multiple Sclerosis

English

Direct Cost of Hepatitis C From the Perspective of the Health Care System for the Federal Government Employees in Mexico

English

Pmd134 - Medical Device Appraisal in the Uk: What Are the Common Pitfalls of Manufacturer Literature Reviews?

English

Using Translatability Assessment to Refine a Patient- Reported Outcome (PRO) Measure During the Development Process

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Public Health

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

Subjective Financial Burden Among German Cancer Patients - Relationship of the Patients’ Economic Situation and Subjective Distress

Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward

HT3 Understanding the Complexity of HTA Networks

Pmu72 - Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the Fda, 2015-2016

Pnd79 - Reduced Healthcare Resource Utilisation for Patients Treated With Delayed Release Dimethyl Fumarate vs Injectable Therapies: Findings From a Real-World Cross-Sectional Study of Ms Patients

Pnd96 - Four-Year Resource Use and Costs Associated With Administration and Monitoring of Disease Modifying Drugs in Patients With Multiple Sclerosis

Direct Cost of Hepatitis C From the Perspective of the Health Care System for the Federal Government Employees in Mexico

Pmd134 - Medical Device Appraisal in the Uk: What Are the Common Pitfalls of Manufacturer Literature Reviews?

Using Translatability Assessment to Refine a Patient- Reported Outcome (PRO) Measure During the Development Process